MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-GJ-01-0000347
VNB Pharma Private Limited
VNB Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.28 Lakh
▲ 722% YoY
Net profit · FY 2024
₹51,902
Net margin 2.6%
EBITDA · FY 2024
₹51,902
EBITDA margin 2.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About VNB Pharma Private Limited
Data last updated:
VNB Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51397GJ2020PTC114039. Its GSTIN is 24AAHCV4238M1ZZ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vandanaben Kamleshbhai Patel and Harshilkumar Batukbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 6th Floor 604 Vraj Valencia Opp.C.K.Patel Farm Sola, Ahmedabad, Gujarat, India – 380060.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.28 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹51,902 (net margin 2.6%) and EBITDA of ₹51,902 (EBITDA margin 2.6%).
VNB Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0000347).
Company details
CIN U51397GJ2020PTC114039
Registration Number 114039
Incorporation Date 18 June 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0000347
Recognitions & Rankings of VNB Pharma
Contact details
VNB Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6th Floor 604 Vraj Valencia Opp.C.K.Patel Farm Sola, Ahmedabad, Gujarat, India – 380060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of VNB Pharma Private Limited, buy the company report.
Comprehensive company report
VNB Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of VNB Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of VNB Pharma Private Limited, buy the company report.
Financials of VNB Pharma Private Limited
FY 2024 filings availableVNB Pharma Private Limited reported revenue of ₹20.28 Lakh (up 722% YoY) for FY 2024.
Revenue · FY 2024
₹20.28 Lakh ▲ 722%
Net profit · FY 2024
₹51,902 margin 2.6%
EBITDA · FY 2024
₹51,902 margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 722%
EBITDA CAGR growth
1 year
▲ 522%
3 years · compounded
▲ 63%
Revenue rose 722% in the latest year. EBITDA rose 522% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹51,902 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹51,902 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.6% | |||
| Net Profit Margin | 2.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of VNB Pharma Private Limited, buy the company report.
Board of directors of VNB Pharma Private Limited
VNB Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandanaben Kamleshbhai Patel Also directs: Carecroft Ranip Private Limited, Carecroft K K Nagar Private Limited, Carecroft Jivraj Park Private Limited and 5 more | Director | 18 Jun 2020 | 6 Years 4 Months | Current |
| Harshilkumar Batukbhai Patel | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
VNB Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Renaanj Life Sciences Private Limited | ₹20.37 Lakh (FY 2025) | 37.0% | Hyderabad, Telangana, India | |||
| Krirudraa Pharma Private Limited | ₹20.37 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Shohan Chemical Private Limited | ₹20.37 Lakh (FY 2025) | -85.0% | Delhi, India | |||
| Masa Life Sciences Private Limited | ₹20.36 Lakh (FY 2024) | -9.0% | Varanasi, Uttar Pradesh, India | |||
| Taarmal Bio Care International Private Limited | ₹20.32 Lakh (FY 2025) | 78.0% | Pune, Maharashtra, India | |||
| VNB Pharma Private Limitedthis company | ₹20.28 Lakh (FY 2024) | ₹51,902 | 2.6% | 722.0% | Ahmedabad, Gujarat, India | |
| Ensure Remedies Private Limited | ₹20.26 Lakh (FY 2023) | -42.0% | Rajkot, Gujarat, India | |||
| Sahil Henna India Private Limited | ₹20.25 Lakh (FY 2025) | 106.0% | Faridabad, Haryana, India | |||
| Pich Pharma Private Limited | ₹20.25 Lakh (FY 2025) | 73.0% | Delhi, India | |||
| Melankin Sciences Private Limited | ₹20.24 Lakh (FY 2024) | 4783.0% | Bangalore, Karnataka, India | |||
| Sun Bio-Formulations Private Limited | ₹20.21 Lakh (FY 2022) | -69.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of VNB Pharma Private Limited, buy the company report.
Auditor
VNB Pharma Private Limited is audited by S V RAVAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S V RAVAL & CO | FY 2022 | 131844W |
Shareholding
The shareholding of VNB Pharma Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of VNB Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving VNB Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VNB Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
VNB Pharma Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
VNB Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCV4238M1ZZ | Gujarat | Active | 24 Aug 2020 |
To see the full GST registrations and return filing status of VNB Pharma Private Limited, buy the company report.
Recent activity
VNB Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Kamleshbhai Babaldas Patel ceased to be Director on 21 Jul 2021.
AGM
Vnb Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Vnb Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Kamleshbhai Babaldas Patel ceased to be Director.
Appointed
Harshilkumar Batukbhai Patel was appointed as Director.
Appointed
Kamleshbhai Babaldas Patel was appointed as Director.
Appointed
Vandanaben Kamleshbhai Patel was appointed as Director.
Incorporation
18 Jun 2020
Vnb Pharma Private Limited was registered on 18 Jun 2020 with Roc Ahmedabad & aged 6 years 4 months as per MCA records.
Frequently asked questions
VNB Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 June 2020 (6+ years old) and is registered under CIN U51397GJ2020PTC114039.
VNB Pharma has 2 current directors:
- Vandanaben Kamleshbhai Patel - Director
- Harshilkumar Batukbhai Patel - Director
The latest financial statements of VNB Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of VNB Pharma is 24AAHCV4238M1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of VNB Pharma is U51397GJ2020PTC114039. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VNB Pharma was incorporated on 18 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of VNB Pharma by revenue are Renaanj Life Sciences Private Limited, Krirudraa Pharma Private Limited, Shohan Chemical Private Limited, Masa Life Sciences Private Limited, Taarmal Bio Care International Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kamleshbhai Babaldas Patel ceased to be Director on 21 Jul 2021. Harshilkumar Batukbhai Patel was appointed as Director on 20 Jul 2021. Kamleshbhai Babaldas Patel was appointed as Director on 18 Jun 2020. VNB Pharma has 4 board changes on record in total.
Yes, VNB Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0000347).
The registered office of VNB Pharma is at 6th Floor 604 Vraj Valencia Opp.C.K.Patel Farm Sola, Ahmedabad, Gujarat, India – 380060.
VNB Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.